Caligan Partners LP 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 10:31 am Purchase | 2026-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Caligan Partners LP | 1,635,023 7.200% | 753,490 (+85.47%) | Filing |
| 2026-02-17 5:00 pm Purchase | 2025-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Caligan Partners LP | 881,533 4.900% | 48,200 (+5.78%) | Filing |
| 2025-11-14 2:31 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Caligan Partners LP | 833,333 6.300% | 833,333 (New Position) | Filing |